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Mohammed Alzahrani 
THE EFFECT OF ALTERNATIVE SPLICING ON KEY REGULATORS OF THE 
INTEGRATED STRESS RESPONSE 
The protein kinase General control non-derepressible-2 (GCN2) is a key 
regulator of the Integrated stress response that responds to various stress 
signals, including nutritional deprivation. As a result of high levels of uncharged 
tRNAs during amino acid depletion, GCN2 phosphorylates serine-51 of the α 
subunit of eukaryotic initiation factor-2 (eIF2), a translation factor that delivers 
initiator tRNA to ribosomes. Phosphorylation of eIF2α inhibits general translation, 
which conserves energy and nutrients and facilitates reprogramming of gene 
expression for remediation of stress damage. Phosphorylation of eIF2α also 
directs preferential translation of specific transcription factors, such as ATF4. 
ATF4 reprograms gene expression to alleviate stress damage; however, under 
chronic stress, ATF4 directs the transcriptional expression of CHOP, which can 
trigger apoptosis. Because multiple stresses can induce eIF2α phosphorylation 
and translational control in mammals, this pathway is referred to as the 
Integrated stress response. 
GCN2 and CHOP are subject to alternative splicing that results in multiple 
transcripts that differ in the 5'-end of the gene transcripts. However, the effect of 
the different GCN2 and CHOP isoforms on their function and regulation have not 
been investigated. Our data suggests that GCN2 is alternatively spliced into five 
different transcripts and the beta isoform of GCN2 is most abundant. Also 
alternative splicing of CHOP creates two CHOP transcripts with different 5'-
leaders encoding inhibitory upstream open reading frames that are critical for 
translational control of CHOP during stress. This study suggests that alternative 
splicing can play an integral role in the implementation and regulation of key 
factors in the Integrated stress response. 
Ronald C. Wek, Ph.D., Chair 
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Introduction 
 
Regulation of the initiation phase of protein synthesis by eif2α 
phosphorylation 
In response to environmental stresses, cells trigger repression of 
translation to conserve energy and resources and facilitate reconfiguration of 
gene expression to better alleviate cell damage. A major regulatory mechanism 
underlying translational control involves phosphorylation of the serine-51 residue 
in the alpha subunit of eukaryotic initiation factor-2 (eIF2α). The eIF2 bound to a 
guanosine triphosphate (GTP) recruits an initiator methionyl transfer-ribonucleic 
acid (Met-tRNAiMet) to the 40S ribosome. In addition to other eukaryotic initiation 
factors such as eIF1 and eIF3, this complex constitutes the preinitiation 43S 
ribosome. The 43S ribosome associates with a cap-binding complex, referred to 
as eIF4F that is associated with 7-methyl guanosine constituting the 5'- “cap” of 
mRNAs. The 43S ribosomal complex then scans processively in a 5'- to 3'-
direction along the mRNA in search of an appropriate initiation codon. Once the 
initiation codon, typically an AUG, is recognized via base pairing with the 
anticodon of the initiator tRNA charged with methionine, the 60S ribosome and 
the 40S ribosome are joined to form the competent 80S initiation complex and 
begin the elongation phase of translation. 
During the initiation phase of translation, the GTP bound to eIF2α is 
hydrolyzed to guanosine diphosphate (GDP), and the association of the small 
and large ribosomal subunits is preceded by with the release of eIF2-GDP. The 
eIF2-GDP must be recycled to the active GTP bound form to begin subsequent 
rounds of translation initiation. This eIF2-GDP to eIF2-GTP exchange is 
facilitated by the eukaryotic initiation factor-2B (eIF2B). However, the eIF2B-
mediated recycling process is competitively inhibited by eIF2α phosphorylation, 
which occurs during various cellular stresses (Baird & Wek, 2012; Hinnebusch, 
2005; Jackson, Hellen, & Pestova, 2010). The consequence of lowered eIF2-
GTP is reduced delivery of the initiator tRNA to the 40S ribosome and sharply 
lowered global translation. 
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Family of eIF2α kinases function in the Integrated stress response 
In mammalian cells, four different eIF2α kinases sense cellular stresses 
and trigger global repression of translation initiation (Figure1). Family members 
include heme-regulated inhibitor kinase (HRI or EIF2AK1) that is induced by 
heme-deprivation, heat shock, or oxidative damage (Shao et al., 2001); Protein 
kinase R (PKR or EIF2AK2) which functions in an anti-viral induced by 
interferons; PKR-like endoplasmic reticulum kinase (PERK or EIF2AK3) that is 
stimulated by accumulation of misfolded proteins residing in the endoplasmic 
reticulum (ER); General control non-derepressible-2 (GCN2 or EIF2AK4) that is 
upregulated in nutrient-deprived cells (Figure 1) (Baird & Wek, 2012). While 
activation of each eIF2α kinase leads to repression of global translation initiation, 
eIF2α phosphorylation also facilitates preferential translation of key stress-related 
mRNAs. For example, translation of the Activating transcriptional factor-4 (ATF4) 
is induced by phosphorylation of eIF2α during cellular stress. Selective 
translation of ATF4 has been proposed to occur by a mechanism involving two 
upstream open reading frames (uORF) situated in the 5'-end of ATF4 mRNAs 
(Harding et al., 2000; Vattem & Wek, 2004). In this model of delayed translation 
reinitiation, following translation of the 5’-proximal uORF1 there is retention of the 
40S ribosome on the mRNA, which continues scanning 5’ to 3’ in search of the 
next open reading frame. In non-stressed conditions and low levels of eIF2α 
phosphorylation, ribosomes are proposed to rapidly reacquire eIF2-GTP-Met-
tRNAiMet and translate the next open reading frame, uORF2. The uORF2 
overlaps out-of-frame with the ATF4 coding sequence (CDS) and consequently 
there is minimal expression of ATF4 protein. During stressed conditions and 
elevated levels of eIF2α phosphorylation that reduce eIF2-GTP levels, the 
reinitiating ribosomes require an extended time to reacquire the limited eIF2-
GTP-Met-tRNAiMet. As a consequence of this delay, the 40S ribosome scans past 
the uORF2 initiation codon before acquisition of eIF2-GTP-Met-tRNAiMet that 
allows for reinitiation of translation at the ATF4 CDS (Vattem & Wek, 2004). The 
resulting increase in levels of ATF4 protein leads to increased transcription of 
target genes involved in amino acid metabolism, nutrient uptake, and 
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suppression of oxidation. Because multiple different stresses induce eIF2α 
phosphorylation and preferential translation of ATF4, this pathway has been 
referred to as the Integrated stress response (ISR) (Harding et al., 2003). 
 
Dysfunction in the ISR leads to disease 
Genetic changes in the eIF2α kinases have been linked to pathologies. 
For instance, HRI knockouts in mice are associated with hematological disorders 
such as iron deficiency anemia, erythropoietic protoporphyria and β- thalassemia 
(Chen, 2007). Loss of the antiviral activity of PKR can be demonstrated in rift 
valley fever patients whose clinical signs ranging from an elevated body 
temperature to retinitis, hepatic inflammation, kidney dysfunction, encephalitis, 
lethal hemorrhagic and death (Habjan et al., 2009). Another PKR-associated 
disease is Fanconi anemia complementation group C that is characterized by 
bone marrow failure, congenital defects, and tumor susceptibility (Pang, 
Christianson, Keeble, Koretsky, & Bagby, 2002). In humans, loss of PERK leads 
to Wolcott-Rallison syndrome, which features insulin-dependent diabetes, 
osteoporosis, and growth retardation (Delepine et al., 2000). A recent study has 
reported that GCN2 mutations are the underlying cause of the pulmonary veno-
occlusive disease (PVOD) (Eyries et al., 2014). PVOD is a rare form of 
pulmonary hypertension and characterized by narrow pulmonary veins and 
venules because of increased cell proliferation. In addition, GCN2 is involved in 
cell lipid metabolism (Guo & Cavener, 2007), learning and memory, the survival 
pathway of tumor cells (Costa-Mattioli et al., 2005), immune response and DNA 
repair under the influence of ultraviolet irradiation (UV) (Jiang & Wek, 2005). 
Finally, knocking out ATF4 in mice, the common target of these eIF2α kinases, 
results in abnormal lens morphogenesis, anemia, delayed growth and bone 
development (Masuoka & Townes, 2002; Tanaka et al., 1998). 
 
GCN2 is a multidomain protein kinase activated by diverse stresses  
The protein kinase GCN2 is composed of multiple domains that are 
shared among diverse species, including human, mice, and Drosophila  
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(Berlanga, Santoyo, & De Haro, 1999; Sood, Porter, Olsen, Cavener, & Wek, 
2000). GCN2 domains include the amino-terminal domain (NTD), the partial 
protein kinase domain (pKD), the catalytic protein kinase domain (cKD), the 
histidyl-transfer RNA synthetase (HisRS)-like domain, and the carboxyl-terminal 
domain (CTD) (Figure 2) (Hinnebusch, 2005; Qiu, Dong, Hu, Francklyn, & 
Hinnebusch, 2001; Wek, Jackson, & Hinnebusch, 1989). Each of these domains 
is critical for activation of GCN2 during nutrient deprivation. As will be expanded 
upon below, GCN2 has a number of exons and its alternative splicing can affect 
the expression of GCN2 protein with different domain arrangements. 
The activity of GCN2 is stimulated by mechanisms contributing to the 
accumulation of non-aminoacylated tRNAs. Stressed conditions activating GCN2 
include reduced amino acid availability and high salinity (Zaborske et al., 2009), 
glucose starvation (Yang, Wek, & Wek, 2000), and UV irradiation that have been 
suggested to increase the level of deacylated tRNAs (Kwon et al., 2011). 
Activation of GCN2 by uncharged tRNAs is driven by the HisRS-like domain; 
binding of uncharged tRNAs to HisRS domains overcomes the inhibitory effect of 
CTD and allows GCN2 activation and dimerization (Lageix, Zhang, Rothenburg, 
& Hinnebusch, 2015). To reach the maximum activity of GCN2, GCN2 undergoes 
auto-phosphorylation of the two conserved threonine residues, Thr-882 and -886 
in budding yeast and Thr-898 and -903 in mice, located within the activation loop 
of cKD (Castilho et al., 2014; Romano et al., 1998). The N-terminal portion of 
GCN2 has been proposed to be the docking site of the GCN1-GCN20 complex, 
and deletion of this region in GCN2 thwarts activation of GCN2 by nutrient 
stresses. It is suggested that the GCN1-GCN20 complex is associated with 
ribosomes and may contribute to GCN2 recognition and binding to uncharged 
tRNAs. The pKD lacks critical residues for the kinase activity, but allosterically 
enhances the activation of the neighboring cKD (Garcia-Barrio, Dong, Ufano, & 
Hinnebusch, 2000; Lageix, Rothenburg, Dever, & Hinnebusch, 2014; Sood et al., 
2000). 
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Multiple ISR genes are subject to preferential translation and control cell 
fate during stress 
As a consequence of diverse stress signals, there is induction of eIF2α 
phosphorylation that serves to inhibit overall protein production coincident with 
preferential translation of ATF4 (Baird & Wek, 2012). Induced ATF4 then 
modulates the transcription of a collection of ISR genes involved in restoring 
cellular homeostasis or alternatively, reducing cellular viability. For example, 
CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CHOP) encodes 
the carboxyl-terminal bZIP domain and drives an apoptotic pathway during 
chronic periods of stress (Palam, Baird, & Wek, 2011). CHOP was originally 
discovered as a member of the C/EBP family that inhibits other C/EBP-mediated 
gene transcription by dimerization (Ron & Habener, 1992). Thus, elevated levels 
of CHOP protein may abolish the effect of anti-apoptotic proteins such as B-cell 
lymphoma-2 (Bcl-2) favoring cell cycle arrest and apoptosis (McCullough, 
Martindale, Klotz, Aw, & Holbrook, 2001). 
CHOP also upregulates apoptotic genes such as Bcl-2 interacting 
mediator of cell death (BiM) and death receptor-5 (DR5) (Puthalakath et al., 
2007; Yamaguchi & Wang, 2004). The proapoptotic BiM protein belongs to the 
BCL-2 family and is required for mitochondrial permeabilization and subsequently 
apoptosis. Loss of BiM in mice leads to resistance to ER stress-induced 
apoptosis of renal epithelium (Tabas & Ron, 2011). Another CHOP-targeted 
gene is DR5 that triggers the extrinsic pathway of apoptosis when DR5 is bound 
to a ligand. Ligand binding to DR5 activates caspase-8, which amplifies apoptotic 
signaling by cleaving and activating other procaspases, such as caspases-3, -6, 
and -7, leading to cell death (McIlwain, Berger, & Mak, 2013). DR5 significantly 
mediates apoptotic induction of human tumor cells treated with ER stress agents 
such as thapsigargin (Tg) (Xu, Su, & Liu, 2012; Yamaguchi & Wang, 2004). In 
addition to induced transcriptional expression, CHOP mRNA is preferentially 
translated by eIF2α phosphorylation. The mechanism of induced CHOP 
translation involves a single uORF that serves as a potent inhibitor of CHOP 
translation during non-stressed conditions; however, upon stress and eIF2α 
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phosphorylation, scanning ribosomes can bypass the CHOP uORF and instead 
initiate translation at the downstream coding region of the CHOP mRNA (Palam 
et al., 2011). 
 
Alternative splicing and gene expression 
Alternative splicing is a post-transcriptional mechanism responsible for 
mRNA diversity through various splicing patterns, e.g. exon skipping, alternative 
3'- and 5'-splice sites, mutually exclusive exons, and intron retention. Alternative 
splicing dictates which portions of the genetic sequences are included in and/or 
excluded from encoded mRNAs. These splicing changes can alter the coding 
sequence and thus modify the domain arrangement of the synthesized protein. 
Alternative splicing can also change the 5'- or 3'-untranslated regions (UTR) of 
the transcript that can influence mRNA stability or levels of translation (Kalsotra & 
Cooper, 2011). Differences in the 5’-UTRs of the mRNAs can also result from 
differences in transcriptional start sites, and selection of polyadenylation 
recognition sequences that define the site for pre-mRNA cleavage and 
polyadenylation. These differences in pre-mRNA processing can alter the 
presence of uORFs in the 5'-end of the mRNAs or alternatively modify protein or 
miRNA binding sequences in the 3'-portion of the transcript that direct mRNA 
turnover (Stamm et al., 2005). 
Splicing of the pre-mRNA is mediated by the spliceosome. Spliceosomes 
are central for identifying conserved sequences located at the exon and intron 
junctions of introns, and the spliceosome in conjunction with associated factors 
can recognize splicing enhancers and silencers that determine which introns are 
removed or retained. The spliceosome is a protein complex encompassing small 
nuclear RNAs (snRNA) and snRNA-associated proteins to form small nuclear 
ribonucleoproteins (snRNP) (Goren et al., 2006). The protein complex is 
assembled by the binding of U1 snRNP to the conserved AG dinucleotide at the 
5'-splice site of the nascent transcript via base pairing. Splicing factor U1 and U2 
auxiliary factor (U2AF) are attached to consensus sequences constituting the 3'-
splice site portion; these sequences represent the branch point, polypyrmidine 
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tract, and terminal AG dinucleotide. Together, U1 and U2AF comprise the early 
or commitment complex that is joined by U2 snRNP at the branch point forming 
the A complex. The A complex recruits a trimeric complex containing U4, U5, and 
U6 snRNPs to create the B complex. This is followed by the formation of the C 
complex due to conformational changes in which U1 snRNP is replaced with U6 
snRNP at the 5'-splice site and U1 and U4 snRNPs are released from the 
complex (Black, 2003). 
Chemically, the spliceosome complex performs two transesterification 
reactions; the first reaction commences by a cleavage between the 5’-exon 
junction and intron caused by the nucleophilic attack of the 2'-hydroxyl group of a 
conserved adenosine at the branch point on the phosphate at the 5'-splice site. 
This reaction leads to formation of a phosphodiester linkage between the 5'-end 
of the intron and 2’-OH of the branch point in a lariat configuration. The second 
transesterification reaction occurs when the free reactive 3'-OH at the 3'-end of 
the released exon attacks the phosphodiester bond connecting the 3'-end of the 
intron to the 5'-end of the downstream exon. The two exons are ligated and an 
lariat intron is excised (Staley & Guthrie, 1998). 
 
Alternative splicing of GCN2 mRNA 
GCN2 is alternatively spliced into at least three different transcripts, 
designated alpha (αGCN2), beta (βGCN2), and gamma (γGCN2) that effect the 
coding sequence and expressed N-terminal portion of GCN2. These GCN2 
splicing variants were first identified by using rapid amplification cDNA ends (5’-
RACE) and sequencing methods (Sood et al., 2000). The GCN2 mRNA is 
ubiquitously expressed and abundant in brain and liver tissues (Berlanga et al., 
1999); however, alpha and gamma isoforms of GCN2 were restricted to brain 
and testis (Sood et al., 2000). Therefore, there can be variations in the NTD and 
pKD regions of GCN2 that are generated by these splicing events. 
Analysis of CHOP expressed sequence tags (EST) suggests that CHOP is 
also subject to alternative splicing, with two isoforms based on the inclusion or 
exclusion of the second exon. Although CHOP expression is widely distributed 
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among tissues, the levels of CHOP protein are low during non-stressed 
conditions. By contrast, synthesis of CHOP protein is induced during stress and 
this transcriptional factor is then translocated to the nucleus to mediate 
transcriptional regulation (Tabas & Ron, 2011). 
 
Questions addressed in this thesis research 
In this study, we investigated the effect of alternative splicing on the key 
ISR regulators, GCN2 and CHOP. Although GCN2 and CHOP isoforms have 
been suggested, their differential expression among tissues and functional roles 
are still obscure. We addressed several questions. First, what are the GCN2 and 
CHOP splicing variants? Second, are there differences in the regulation of CHOP 
translation by the alternative splicing in the 5'-portion of the CHOP mRNA during 
non-stressed and stressed conditions? Finally, are there differences in the 
expression of GCN2 and CHOP transcripts among different mouse tissues? 
Addressing these fundamental questions will provide new insight into the roles of 
alternative splicing in the regulation and functions of ISR. 
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Figure 1: The Integrated stress response results in inhibition of overall protein 
alongside of preferential translation of some stress-related gene transcripts. The 
eukaryotic initiation factor-2 alpha (eIF2α) kinases are the Heme-regulated 
inhibitor (HRI), Protein kinase R (PKR), PKR-like endoplasmic reticulum kinase 
(PERK), and General control non-derepressible-2 (GCN2). Each of these protein 
kinases is activated by different stress signals. Phosphorylation of eIF2α inhibits 
general protein production, but selectively induces the translation of specific 
mRNAs, such as the activating transcriptional factor-4 (ATF4). ATF4 activates 
the transcription of other stress-related genes to ameliorate the stress response 
or induce apoptosis by C/EBP homologous protein (CHOP). ER, endoplasmic 
reticulum; UV, ultraviolet irradiation; and P, phosphorylation. 
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Figure 2: Protein domains of the protein kinase GCN2. GCN2 consists of 
multiple domains that interact with each other and other proteins for regulation of 
GCN2 activity. GCN2 domains include the N-terminal domain (NTD), the partial 
kinase domain (pKD), the catalytic kinase domain (cKD), the histidyl-transfer 
RNA synthetase-like domain (HisRS), and the C-terminal domain (CTD). The 
length of each domain is represented in amino acid residues, and domains were 
demarcated by using the software program Pfam.  
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Methods and Materials 
 
Identification of GCN2 variants in the genome 
The sequence of GCN2 isoforms were derived from the genome database 
created by University of California, Santa Cruz (UCSC). We used a sequence 
alignment program called CLUSTALW to identify the unique sequence of each 
splicing isoform based on the sequence differences compared to the sequence of 
βGCN2. The unique sequence of each isoform was used as a query in the 
BLAST program, provided by National Center of Biotechnology Information 
(NCBI), to search the mouse database for ESTs. Thus, we addressed whether 
the GCN2 splicing variant is likely to be expressed. 
 
Tissue homogenization and RNA isolation 
The protocols of animal study were approved by the Institutional Animal 
Care and Use Committees at Rutgers University and the Indiana University 
School of Medicine. Different mouse organs including whole brain, liver, and 
testis were extracted from Cre-mediated red fluorescent reporter transgenic mice 
with C57BL/6 background (Banks et al., 2011). The other liver tissues, used for 
CHOP PCR, were also derived from Cre-negative mice born after breeding 
between C57BL/6 mice carrying floxed alleles of ATF4 and C57BL/6 mice 
carrying one allele of Cre recombinase driven by an albumin promoter. The Cre-
negative mice were intraperitoneally (IP) injected with 1 mg of tunicamycin (Tm)/ 
kg body weight or 0.3% DMSO in phosphate-buffered saline (PBS) as a control, 
i.e. non-treated mice. These mice were sacrificed by decapitation after 6-hour-
treatment with Tm (Fusakio et al., 2016). The tissues were rinsed with cold PBS 
and immediately frozen in liquid nitrogen after being covered with aluminum foil. 
By using clear mortar and pestle placed on dried ice, each organ was 
homogenized in the presence of liquid nitrogen and the ground tissues were 
frozen at - 80 °C. 2-30 mg of ground tissues were used for RNA purification. 
Addition of 1 ml of TRIzol reagent (Ambion, Life Technologies) was used to 
extract RNA after being released from disrupted cells by a mechanical force. 
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After 5 minutes (min) of incubation at room temperature (RT), 200 μl of 
chloroform was added and solution was incubated for 3 min at RT. The solution 
was clarified by centrifugation at 12,000 relative centrifugal force (RCF) for 15 
min at 4 °C, and supernatant was collected. To precipitate RNA, 500 μl of 
isopropyl alcohol was added to supernatant and incubated for 10 min at RT. 
Following centrifugation at 12,000 RCF for 10 min at 4°C, pellets were collected 
and washed with 1 ml of 75 % ethanol. Ethanol was removed following an 
additional centrifugation at 7,500 RCF for 5 min at 4 °C, and pellets were placed 
on ice. 
RNA samples were further purified by using the RNeasy® Plus Mini Kit 
(50) (QIAGEN); pellets were dissolved in 100 μl of RNase free water. 350 μl of 
freshly made solution of RLT buffer and β-mercaptoethanol was added to the 
dissolved pellets. After mixing the solution by a vortex, 250 μl of absolute ethanol 
was added creating small precipitated particles. The total volume, 700 μl, was 
transferred to an RNase easy column that was subjected to centrifugation at 
8,000 RCF for 15 seconds (sec). The columns were washed with 500 μl of an 
ethanol-added RPE buffer after being centrifugation at 8000 RCF for 15 sec. A 
final centrifugation was carried out for the columns at 12,000 RCF for 1 min. The 
final step in the purification involved addition of 35 μl RNase free water to 
columns, which were incubated for 5 min at RT before the RNA was eluted at 
14,000 RCF for 1 min. The RNA concentrations were measured by using a 
Nano-Drop spectrophotometer. 
 
Reverse transcription and PCR 
Purified total RNA was reverse transcribed to produce cDNAs using the 
Taqman regent and Multiscribe Reverse Transcriptase (Applied Biosystems). In 
brief, 2 µg of purified RNA was diluted in 19 µl of RNase free water was added to 
30 µl of the Taqman reagent mix containing 10X Taqman reagent, 25 mM of 
magnesium chloride, 2.5 mM deoxynucleotide mix, 1.25 mM random hexamers, 
and 20 Units RNase inhibitor. The addition of 1 µl of Multiscribe Reverse 
Transcriptase brought the volume to 50 µl. The reverse transcription was 
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performed for 48 minutes at 48°C after activating the enzyme at 25 °C for 10 min. 
To inactivate the enzyme and the reverse transcription, the reaction was exposed 
to high temperature, 95 °C for 5 min, and the concentration of cDNA was 
measured by the Nano-Drop spectrophotometer. 
To detect GCN2 transcripts, we designed multiple sets of primers that 
were specific to each isoform of GCN2 (Table 1). PCR reactions contained 12.5 
μl of R-Taq Master Mix (Bullseye), 1 μl of the specific forward and reverse 
primers corresponding to each isoform, 1 μl of a template DNA (0.1-1 µg), and 
9.5 μl of distilled water. The PCR reaction was programmed for 35 cycles in 
which each cycle featured three steps; the denaturation step was set at 94 °C for 
30 sec; the annealing step was set at 60 °C for 30 sec; the elongation step was 
set at 72 °C for 15 sec. An additional 10 min-elongation step was assigned 
before inactivating the polymerase at 4 °C. The amplicons were separated by 
electrophoresis using an electrical field of 104-116 Volts applied on 1.5 % of an 
agarose gel. Adding ethidium bromide to the gel helped visualize the DNA bands 
separated by gel electrophoresis and UV light. 
Similarly, we relied on PCR to detect CHOP variants using specific 
primers designed upon the alternative exon of CHOP (Table 2). The PCR 
reaction was set up as described earlier with similar programming steps, except 
for the number of PCR cycles and the annealing temperature; PCR cycles were 
reduced to 20 cycles, and the annealing step was set at 72 °C for 30 sec. 
 
Quantitative PCR analysis 
To estimate the abundance of the βGCN2 within different mouse tissues, 
we used the real time-polymerase chain reaction (RT-PCR). First, we amplified a 
PCR product containing only βGCN2. Then, we made serial dilutions of the 
concentrated βGCN2 ranging from 1 picomole (pmol) to 1x10-08 pmol. To build a 
stable and reproducible standard curve for βGCN2, 5 µl of each dilution of 
βGCN2 was plated in triplicates and mixed with 15 µl of the SYBR mix including 
1 µl of 5 µM forward and reverse βGCN2 primers, 3 µl of distilled water, and 10 
µl of SensiMix™ SYBR® No-ROX Kit, BIOLINE. Next, we performed RT-PCR on 
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different mouse tissues using the specific βGCN2 primers. This RT-PCR 
generated double stranded-DNAs of βGCN2 that were detected by the 
fluorescent (SYBR Green) dye. Results of RT-PCR were represented as the 
mean of cycle threshold (Ct) values of the three independent samples, i.e. 
triplicates, plus or minus the standard deviation (± SD). The abundance of 
βGCN2 in different samples of mouse tissues was deduced by comparing the Ct 
values of βGCN2 in each sample to that of the standard curve.  
 
Plasmids and dual luciferase reporter assays 
Four different plasmids were utilized in this study; two pcDNA3.1-derived 
plasmids expressing the full sequence of either CHOP variant-1 (CHOP v1) or 
CHOP variant-2 (CHOP v2) were used to check the specificity of CHOP primers. 
As a PCR template for CHOP primers, we first used the full CHOP v1 cDNA 
plasmid (CHOP v1 plasmid) encoding 1 kilobase of CHOP promoter upstream of 
the 5'-leader and CDS of CHOP v1 (Young, Palam, Wu, Sachs, & Wek, 2016). 
To construct the full version of CHOP v2 cDNA (CHOP v2 plasmid), the CHOP 
v1 plasmid was digested with HindIII and BsmBI restriction enzymes (New 
England BioLabs) to remove the 5'-leader of CHOP v1 and this portion was 
replaced with the analogous DNA portion encoding the 5’-leader of CHOP v2 
which was synthesized by Integrated DNA Technologies (IDT). The resulting 
CHOP v2 plasmid was then utilized as a PCR template to confirm that the CHOP 
primers in Table 2 are specific to their corresponding transcripts. 
The other two pGL3-derived plasmids encoding either CHOP v1 uORF 
(CHOP v1-luc) or CHOP v2 uORF (CHOP v2-luc), each with the start codon of 
CHOP CDS fused in-frame to the coding sequence of firefly luciferase. 
Transcription of the CHOP-Luc fusion genes were expressed constitutively from 
a thymidine kinase promoter (TK) as previously described (Palam et al., 2011; 
Young et al., 2016). To transfect MEF cells with CHOP v1-luc or CHOP v2-luc 
constructs, we first cultured MEF cells for 24 hours and then split cells into two 
six-well plates designated as CHOP v1 plate and CHOP v2 plate. MEF cells in 
each plate were then transiently co-transfected with either CHOP v1-luc or 
15 
CHOP v2-luc plasmids and a Renilla luciferase construct based on the protocol 
of FuGENE 6 transfection reagent (Roche Applied Science). After incubating the 
cells for 24 hours, triplicate wells within each plate were treated with 0.1 μM of Tg 
or no ER stress agent and followed by an additional 12 hour incubation (Palam et 
al., 2011). MEF cells were lysed by adding 500 µl of 1X passive lysis solution 
(Promega) to each well followed by shaking for 15 min. Following centrifugation 
at 13,000 RCF for 2 min at 4°C, 20 µl of the supernatant was used to conduct the 
dual-luciferase assay. The luciferase activity was represented as relative light 
units of the ratio of firefly to Renilla luciferase units (Palam et al., 2011). Relative 
values from the triplicate wells treated with thapsigargin for 12 hours were 
averaged and normalized to the mean value of the non-treated triplicate wells. 
Relative values are shown as CHOP v1 and CHOP v2 histograms with the SD 
indicated. 
 
Statistical analysis 
Relative values of stressed and non-stressed CHOP v1 and CHOP v2 with 
± SD are derived from biological triplicates. By using the two-tailed student’s t-
test, P values were calculated to indicate the significance of the test. If P values 
were 5% or less, the test was considered statistically significant and indicated by 
"*". 
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Table 1: Sequences of primer sets used for the identification of GCN2 isoforms. 
Sets Forward primer sequence Reverse primer sequence Amplicons 
Pair 1 
5'-CATCCGCTTGTATGAG 
CAGCTA-3' 
5'-CTGACGTTCTCGCCT 
GGA-3' 
αGCN2 
Pair 2 
5'-CCTACATACCCAGATG 
TAGTTCCCGAA-3' 
5'-CCAGCATTTCTTCATG 
GAAAGACTTTGGTG-3' 
βGCN2 
Pair 3 
5'-GCGGGCTCTTCTAGT 
TCCCGAAAT-3' 
5'-GCCTTTCCAGCATTTC 
TTCATGGAAAGAC-3' 
γGCN2 
Pair 4 
5'-CCAAGACTTCCTGAA 
GAATCCTAGGAGAC-3' 
5'-TGCACTTGTGATTCAC 
AAGTGAAAAATCCTC-3' 
δGCN2 
Pair 5 
5'-CCCACCTACATACCC 
AGATGTGTGATG-3' 
5'-CCTCTTTCCTTCTCTG 
AATCTCGTGGAG-3' 
εGCN2 
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Table 2: Sequences of primer sets used for the identification of CHOP isoforms. 
Sets Forward primer sequence Reverse primer sequence Amplicons 
Pair 1 
5'-CCTGAGGAGAGAGTG 
TTCCAGAAGG-3' 
5'-CGTTTCCTGGGGATG 
AGATATAGGTGC-3' 
CHOP v1 
Pair 2 
5'-CTGAGGAGAGAGAAC 
CTGGTCCA-3' 
5'-ACGCAGGGTCAAGAG 
TAGTGAAG-3' 
CHOP v2 
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Table 3: Sequences of primers used for the identification of firefly luciferase and 
β-actin. 
Amplicons Forward primer sequence Reverse primer sequence 
Firefly luc 
5'-CTCACTGAGACTACATC 
AGC-3' 
5'-TCCAGATCCACAACCTT 
CGC-3' 
β-actin  
5'-TGTTACCAACTGGGACG 
ACA-3' 
5'-GGGGTGTTGAAGGTCT 
CAA-3' 
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Results 
 
Characterization of mouse GCN2 in the genome 
There are five putative GCN2 splicing variants reported in the UC Santa 
Cruz genome database for mice (GRCh38/hg38). To further address the 
existence of GCN2 isoforms in the genome, we searched the EST database of 
NCBI for sequences specific to each isoform of GCN2.  In addition to the 
previous identified splicing variants (Berlanga et al., 1999; Sood et al., 2000), we 
found an EST for a new isoform, εGCN2, with an accession number of 
CD355187, which belongs to Mus musculus cDNA extracted from whole brain. 
Together, these ESTs support the idea that there are several GCN2 isoforms 
expressed in mice. However, there is no EST specific for the delta isoform of 
GCN2 (δGCN2); therefore, we used the δGCN2 primers to amplify and detect the 
δGCN2 mRNA in non-treated MEF cells as a proof of δGCN2 existence in the 
genome (Table 1). After 35 cycles of PCR, we detected low expression of 
δGCN2 in the MEF cells. Next, we cut the δGCN2 band at the size of 170 base 
pairs (bp) in the agarose gel (Figure 3) and extracted δGCN2 DNA according to 
the manufacture’s protocol of QIAquick® Gel Extraction Kit (QIAGEN). The 
extracted δGCN2 DNA was sequenced by GENEWIZ and the sequence of the 
extracted DNA was similar to δGCN2 sequence derived from UCSC, suggesting 
the existence of δGCN2 in the genome. 
 
Mouse GCN2 has five isoforms with different N-termini 
There are three reported variants of GCN2 mRNA, namely alpha, beta 
and gamma (Sood et al., 2000). In addition to alternative splicing of GCN2, the 
three GCN2 isoforms are also suggested to arise from alternative transcriptional 
sites (Sood et al., 2000; Zhang et al., 2002). βGCN2 represents the full-length 
version of GCN2 encoding a large protein of 1648 residues with a molecular 
weight of 186 kilo Dalton (kDa). The number of exons and sequence of these 
GCN2 isoforms were reported (Sood et al., 2000). The five GCN2 isoforms were 
identified in non-treated MEF cells using the specific primers for each isoform 
20 
(Table 1); first, αGCN2 was amplified at 214 bp in the agarose gel; secondly, 
βGCN2 was detected at 211 bp in the gel; third, γGCN2 was observed at 212 bp 
in the gel; lastly, the new delta and epsilon variants of GCN2, δGCN2 and 
εGCN2, were detected with the size of 172 and 214 bp in the agarose gel, 
respectively. Detection of GCN2 splicing variants was confirmed by sequencing 
the GCN2 bands. In addition, the absence of other bands with larger sizes 
emphasizes the specificity of GCN2 primers (Figure 3A). 
The sequence differences between GCN2 isoforms take place within the 
encoded amino terminal domain (Figure 3). βGCN2 represents the full-length 
version GCN2 encoded in 39 exons, and αGCN2 lacks the first five exons of 
βGCN2 representing the sequence of NTD; the first five exons of αGCN2 are 
replaced with an elongated exon as the first and alternative exon of αGCN2 
(Zhang et al., 2002). The gamma transcript contains an alternative exon between 
the second and third exons of the beta transcript. δGCN2 lacks the N-terminal 
domain and parts of the pKD sequence, but includes an extra exon situated 
between the ninth and tenth exons of βGCN2. In addition, δGCN2 transcripts 
encode the shortest protein of GCN2 because the translation initiation codon is 
located within the cKD of GCN2. εGCN2, on the other hand, has an additional 
exon between the first and second exons of βGCN2, but εGCN2 is missing the 
third exon of βGCN2 (Figure 3B). 
 
Expression of βGCN2 transcripts is higher in mouse testis than brain and 
liver 
βGCN2 transcripts are expressed in different mouse tissues including 
whole mouse brain, liver and testis as estimated by RT-PCR. We performed PCR 
using 0.1 µg of mouse brain, liver, or testis cDNAs as templates to amplify the 
βGCN2 DNA at the size of 211 bp. As seen in the PCR result (Figure 4A), the 
intensity of the βGCN2 bands derived from testis, reflects how much βGCN2 
RNA is expressed in this tissue. We suggest that βGCN2 expression is higher in 
testis than the other tissues. To further support this claim, we developed a 
standard curve for βGCN2 to be used as a control for βGCN2 measurement in 
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the different mouse tissues. PCR of different cDNA concentrations, 0.2 μg, 0.4 
μg, 0.6 μg, 0.8 μg, 1 μg, and 1.2μg, from the whole mouse brain, liver or testis 
was used to estimate the Ct values for each sample. The Ct values of these 
samples were then compared to that of the βGCN2 standard curve to measure 
the amount of βGCN2 cDNA prepared from each sample. The βGCN2 
measurement was calculated by plotting the Ct values of each sample in the Y 
variable in the slope equation of βGCN2 standard curve (Y = - 3.7254X - 4.1254) 
(Table 4). Ct values are inversely proportional to the number of βGCN2 
transcripts. Based on RT-PCR analysis, the Ct values of liver samples were 
lower than of brain samples, indicating a higher amount of βGCN2 mRNAs in 
mouse liver tissues. The testis samples showed the lowest Ct values, revealing 
the highest levels of βGCN2 transcripts (Figure 4B). Therefore, βGCN2 mRNAs 
are abundant in testis, moderate in liver, and lowest in brain tissues. 
 
The two isoforms of mouse CHOP are determined by the inclusion or 
exclusion of the second exon 
CHOP encodes a 29-kDa protein composed of 168 amino acids (Ron & 
Habener, 1992). CHOP mRNAs are derived from 4 exons; the first two exons 
represent the 5'-leader of CHOP and the remaining 3 and 4 exons encode the 
bZIP domain. As a consequence of the alternative splicing at the second exon, 
the sequence of the 5'-leader of CHOP is varied, creating two isoforms-called 
CHOP v1 and CHOP v2. CHOP v1 mRNA contains 4 exons in which the second 
exon is included, whereas CHOP v2 mRNA lacks the sequence of the alternative 
exon and thus includes 3 exons. CHOP v1 mRNA contains an uORF encoding a 
34-residue polypeptide that proceeds the CHOP CDS. Due to the removal of the 
second exon containing a stop codon, the CHOP v2 uORF overlaps with the 
CHOP CDS in a different reading frame, encoding a larger polypeptide of 87 
residues (Figure 5A) (Palam et al., 2011). 
To distinguish between the two CHOP isoforms, we designed specific 
CHOP primers based on the presence or absence of the second exon (Table 2). 
Using the CHOP primers with 0.01 µg of either CHOP v1 plasmid or CHOP v2 
22 
plasmid DNA was sufficient to check for the specificity of CHOP primers. As 
expected, CHOP v1 band was only detected using the CHOP v1 plasmid 
template at the size of 214 bp, whereas CHOP v2 was found only with the CHOP 
v2 plasmid template at 207 bp in the agarose gel electrophoresis (Figure 5B). 
We next used the CHOP v1 and CHOP v2 primer sets in the PCR analysis 
to detect whether variants were in liver tissues of mice treated via IP with vehicle 
or tunicamycin, another ER stressor that blocks N-glycosylation. CHOP v1 DNA 
band was amplified in the Tm-treated liver template at the size of 214 bp, 
whereas CHOP v2 band was detected in the Tm-treated liver at the size of 207 
bp. In comparison to CHOP v1, the diminished intensity of CHOP v2 band 
suggests low expression of CHOP v2 transcript in liver tissues (Figure 5C). 
 
CHOP transcripts are preferentially translated during cellular stresses 
The 5'-leader of CHOP v1 contains an uORF, applying an inhibitory effect 
on CHOP mRNA translation in non-stressed conditions. Repression of CHOP 
translation is overcome by eIF2α phosphorylation in response to diverse 
stresses. Preferential translation of CHOP is facilitated by a mechanism involving 
ribosomal bypass of the inhibitory effect of CHOP v1 uORF (Palam et al., 2011). 
To address whether the alternative splicing in the 5'-leader of CHOP can affect 
the regulation of CHOP translation, we transiently transfected a firefly luciferase 
reporter encoding either the 5’-leader sequences of CHOP v1 or CHOP v2. In 
each reporter construct, the initiation codon of the CHOP was fused in-frame with 
the luciferase coding sequence. Both reporters were transcriptional expressed 
using a constitutive TK promoter. The CHOP v1-Luc and CHOP-Luc reporters 
were transiently transfected in wild-type MEF cells, in conjunction with a Renilla 
luciferase plasmid for normalization. The transfected cells were then cultured in 
the presence or absence of thapsigargin, a potent inducer of ER stress. We 
found more than a 2-fold induction of luciferase activity expressed from the 
CHOP-luciferase reporters, consistent with preferential translation of CHOP upon 
induced eIF2α phosphorylation and stress (Figure 6).  
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Figure 3: Semi-quantitative PCR analysis of GCN2 variants in non-treated MEF 
cells and their different exon arrangement in the 5'-portion of the GCN2 gene. (A) 
GCN2 variants, including alpha (αGCN2), beta (βGCN2), gamma (γGCN2), delta 
(δGCN2), and epsilon (εGCN2) transcripts, were detected in non-treated MEF 
cells at the expected sizes; αGCN2 at 211 base pairs (bp), βGCN2 at 211 bp, 
γGCN2 at 212, δGCN2 at 172, and εGCN2 at 214 bp. The absence of larger 
bands supports specificity of the PCR primers. Also β-actin mRNA was 
measured in the MEF cell preparations as a control. (B) βGCN2 is the full-length 
canonical sequence and αGCN2 mRNA contains a large exon that is either 
shortened or absent in other isoforms. Both γGCN2 and δGCN2 mRNAs have an 
additional exon that is spliced out in the other variants. In comparison to γGCN2 
and δGCN2, εGCN2 mRNA has also a spliced exon corresponding to the third 
exon of βGCN2 transcript. The common exons are represented as black boxes, 
whereas the white boxes indicate the exons unique to the spliced variant; the 
small white and/or black boxes represent the 5'-UTR of GCN2 isoforms; introns 
are illustrated as lines connecting exons designated as boxes. 
  
24 
 
Figure 4: Expression of the beta isoform of GCN2 (βGCN2) and measurement of 
βGCN2 in different mouse tissues. (A) βGCN2 mRNA is expressed in wild type 
(WT)-untreated (NT)-whole mouse brain, liver and testis. Also, β-actin mRNA 
was detected in the indicated tissues as an internal control. (B) The βGCN2 
standard curve is created by the quantitative RT-PCR of serial dilutions of 
βGCN2 DNA. This standard curve can be used to determine how many βGCN2 
transcripts in unknown samples such as those derived from the whole mouse 
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brain, liver, and testis. βGCN2 transcripts are estimated in the different mouse 
tissues by plotting the Y variable of the slope of βGCN2 standard curve with the 
values of cycle threshold (Ct) of unknown samples (Y = - 3.7254X - 4.1254). 
Thus, the X variable, which represents the DNA concentration of βGCN2, can be 
calculated. According to the results of RT-PCR, βGCN2 expression is high in 
testis, moderate in liver and low in brain.  
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Table 4: RT-PCR result using different sample concentrations from different 
mouse tissues and the calculated BGCN2 transcripts in each sample. 
Sample 
concentrations 
(μg) 
WT-brain WT-liver WT-testis 
Ct values 
βGCN2 
amount 
Ct values 
βGCN2 
amount 
Ct values 
βGCN2 
amount 
0.2 25.16 1.4x10-08 23.14 4.8x10-08 21.56 1.3x10-07 
0.4 23.12 4.9x10-08 21.39 1.4x10-07 20.02 3.3x10-07 
0.6 22.29 8.1x10-08 20.63 2.3x10-07 19.42 4.8x10-07 
0.8 21.98 9.8x10-08 20.44 2.6x10-07 19.36 5x10-07 
1 21.20 1.6x10-07 20.34 2.7x10-07 18.75 7.2x10-07 
1.2 20.44 2.6x10-07 19.64 4.2x10-07 18.64 7.8x10-07 
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Figure 5: Semi-quantitative PCR analysis of CHOP splicing variants in liver 
tissues. (A) CHOP v1 mRNA contains four exons, whereas CHOP v2 mRNA 
lacks the second exon of CHOP v1. The 5'-leader of CHOP is encoded within the 
first and second exons, while the coding sequence is encoded within the third 
and fourth exons of CHOP. (B) As expected, CHOP v1 primers amplified CHOP 
v1 transcripts at the size of 214 bp in the CHOP v1 plasmid template containing 
the full sequence of CHOP v1. While, CHOP v2 isoforms were detected at the 
size of 207 bp in the CHOP v2 plasmid expressing the whole sequence of CHOP 
v2. The presence of a single band amplified by the corresponding primers in 
each plasmid indicates the specificity of CHOP primers. (C) CHOP v1 and CHOP 
v2 are also expressed in tunicamycin-treated liver tissues at the expected sizes 
214 bp and 207 bp, respectively. Also, β-actin was used as a control. The 
common exons are represented as black boxes, and the alternative exon is 
shown as a white box; small white and/or black boxes represent either the 5'- or 
3'- UTRs of CHOP transcripts; introns are illustrated as lines connecting exons; 
P1, primers specific for CHOP v1 detection; P2, primers specific for CHOP v2 
detection; NT, non-treated liver tissues; Tm/6hr, liver tissues treated with 
tunicamycin for 6 hours.  
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Figure 6: Representation of the two CHOP constructs (CHOP v1-luc and CHOP 
v2-luc), and their luciferase activity in normal and stressed conditions. (A) The 
CHOP v1-luc plasmid is constructed to have an uORF preceding the luc ORF to 
determine the effect of CHOP v1 uORF on luciferase activity. The CHOP v2-luc 
plasmid is constructed to have CHOP v2 uORF that overlaps out-of-frame with 
the luciferase CDS. (B) In comparison to non-treated (NT) MEF cells, CHOP v1 
and CHOP v2 showed nearly a 2.5-fold induction of luciferase activity in MEF 
cells treated with thapsigargin (Tg), an ER stress agent, for 12 hours (12 hr). 
These findings indicate that CHOP v1 and CHOP v2 are preferentially translated 
during ER stress.  
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Discussion 
The mammalian eIF2α kinases respond to alterations in the cell 
homeostasis initiated by environmental and physiological stresses. For example, 
the protein kinase GCN2 is a multidomain protein that phosphorylates Ser-51 of 
eIF2α in response to nutrient starvation. GCN2 senses the deficiency of amino 
acids through binding of uncharged tRNAs to the HisRS domain of GCN2. This 
binding elicits a conformational change that activates the cKD leading to high 
levels of eIF2α phosphorylation (Castilho et al., 2014). 
mRNA diversity is driven by regulatory mechanisms including alternative 
splicing and/or alternative utilization of promotors. As a result, transcripts acquire 
different N-terminal sequences or 5'UTRs among transcripts (Landry, Mager, & 
Wilhelm, 2003). For example, αGCN2, βGCN2, γGCN2 have been proposed to 
be a consequence of alternative splice sites and different promoters that lead to 
different transcriptional start sites (Sood et al., 2000; Zhang et al., 2002). 
Similarly, the new isoforms, δGCN2, and εGCN2, likely arise from different 
promoters and alternative splicing sites. In addition to alternative usage of 
promoters and alternative splicing, GCN2 may be subject to alternative 
polyadenylation resulting in different 3'-UTRs encoded in αGCN2 and γGCN2 
transcripts. The 3'-ends of mRNAs are known to be targeted by microRNAs, 
short non-coding RNAs, that negatively regulate gene expression (van 
Kouwenhove, Kedde, & Agami, 2011).  
Mouse GCN2 is suggested to produce five transcripts, αGCN2, βGCN2, 
γGCN2, δGCN2, and εGCN2, which differ in the encoded N-terminal polypeptide 
sequences (Figure 3). The N-terminal domain of GCN2 is essential for GCN1 
binding in yeast (Sattlegger & Hinnebusch, 2000). The conservation of key 
residues within the NTD among GCN2 orthologues implies a similar mechanism 
of function (Nameki et al., 2004). These findings suggest that the activities of all 
GCN2 isoforms are not uniformly functional or regulated in a similar fashion. For 
example, δGCN2 encodes a shorter protein because it lacks the NTD and pKD. 
The shorter version of GCN2 protein may resemble the function of the truncated 
protein kinase of baculovirus that dampens the kinase activity of human and 
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yeast eIF2α kinases (Dever et al., 1998). However, the negative feedback of the 
δGCN2 on eIF2α kinases awaits further biochemical analysis. 
To evaluate the differential expression of GCN2 transcripts, RT-PCR 
results for βGCN2 revealed that βGCN2 transcripts are more abundant in the 
testis tissue than in the liver tissue, while the brain tissue shows the least 
expression of βGCN2 in non-stressed conditions. In the future, two questions will 
be worth pursuing: first, which GCN2 isoform is dominant during stress? Second, 
which tissues would the stress-dominant GCN2 transcript be most highly 
expressed? Detection of βGCN2 in different mouse tissues is consistent with 
those reported (Berlanga et al., 1999; Sood et al., 2000). The absence of the two 
additional GCN2 variants, δGCN2 and εGCN2, in mouse brain, liver, and testis 
tissues suggests that each is minimally expressed or restricted to other tissues. If 
δGCN2 and εGCN2 are tissue-specific transcripts, this will open new avenues for 
diagnostic biomarkers or therapeutic targets. 
CHOP is another ISR key regulator that determines the cell fate during 
stress. As a result of eIF2α phosphorylation in stressed cells, the cells produce 
ATF4 proteins in an attempt to restore cellular homeostasis; alternatively, ATF4 
protein promotes CHOP transcriptional expression during prolonged stressed 
conditions. Consequent to increased eIF2α phosphorylation, accumulation of 
CHOP mRNA induces an apoptotic pathway leading to a program of gene 
expression that triggers cellular death. 
CHOP mRNA is alternatively spliced at the second exon into CHOP v1 
and CHOP v2 variants. Both CHOP transcripts encode the full-length protein, but 
differ in their 5'-portions that carry out a regulatory role in CHOP translation. 
CHOP v1 transcript appears to be more highly expressed compared to CHOP v2 
in tunicamycin-treated liver tissues (Figure 5C). This finding may indicate that 
there is differential expression of CHOP transcripts among mouse tissues. 
To address the effect of the different 5'-leaders of CHOP on the regulation 
of CHOP translation, we developed the dual luciferase assays for CHOP v1-luc 
and CHOP v2-luc constructs (Figure 6). Consistent with previous results (Palam 
et al., 2011), CHOP v1 uORF functions to prevent translation at the downstream 
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coding sequence of CHOP mRNA in non-stressed cells. The inhibition of CHOP 
translation has been attributed to a specific sequence within CHOP v1 uORF that 
is conserved among eukaryotes. The uORF sequence, encoding IFIHHHT 
residues, has been suggested to cause a ribosomal stall blocking other 
elongating ribosomes, and thus contributes to reduced CHOP proteins in non-
stressed conditions (Young et al., 2016). However, CHOP proteins under 
stressed conditions, are synthesized by the ribosomal bypass model. In the 
bypass model, the scanning ribosomes ignore the initiation codons of CHOP v1 
uORF in part because of the poor Kozak of its initiation codons; instead, the 
ribosomes recognize the downstream initiation codon of CHOP CDS and direct 
translation of the CHOP CDS (Palam et al., 2011). 
Likewise, the CHOP v2 uORF is suggested to control CHOP translation in 
a similar fashion to the CHOP v1 uORF as illustrated in the luciferase reporter 
assay (Figure 6). Although CHOP v2 uORF is suggested to confer regulation of 
CHOP translation as described for CHOP v1, the CHOP v2 uORF lacks the 
inhibitory sequence, i.e. IFIHHHT, positioned in the CHOP v1 uORF. Therefore, 
the notion of regulated CHOP protein synthesis relies on another mechanism for 
CHOP v2 mRNA. The CHOP v2 uORF overlaps out-of-frame with the CHOP 
CDS, suggesting that the uORF serves as an inhibitor to translation by allowing 
translating ribosomes to elongate past the initiation codon of the CHOP CDS. 
After translation of the CHOP v2 uORF, ribosomes would be 3’ of the of the CDS 
initiation codon and require substantial 3’ to 5’ scanning, which is not thought to 
occur. It is suggested that the CHOP V1 mRNA is subject to nonsense mediated 
decay, or similar mRNA surveillance systems that may be triggered by stalled 
ribosomes in the CHOP v1 uORF. The apparent absence of stalled ribosomes in 
the CHOP v2 uORF may indicate differences in mRNA turnover, which could be 
important for CHOP expression late in the progression of the stress responses. 
Differences between CHOP v1 and CHOP v2 mRNA decay during ER stress 
responses warrants future investigation.  
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